FRANCISCO LÓPEZ MEDRANO-rekin lankidetzan egindako argitalpenak (16)

2024

  1. Evolution of the impact of the COVID-19 pandemic on heart transplant recipients: Decreasing risk, improving perspective

    Transplant Infectious Disease, Vol. 26, Núm. 2

2021

  1. Impact of late-onset cytomegalovirus infection in the development of cardiac allograft vasculopathy in heart transplant recipients

    Transplant Infectious Disease, Vol. 23, Núm. 2

2020

  1. COVID-19 in solid organ transplant recipients: A single-center case series from Spain

    American Journal of Transplantation, Vol. 20, Núm. 7, pp. 1849-1858

  2. Effect of coronavirus disease 2019 in pulmonary circulation. The particular scenario of precapillary pulmonary hypertension

    Diagnostics, Vol. 10, Núm. 8

  3. Heart transplant during the COVID-19 pandemic: follow-up organization and characteristics of infected patients

    Revista Espanola de Cardiologia, Vol. 73, Núm. 12, pp. 1077-1080

2015

  1. Current preventive strategies and management of Epstein-Barr virus-related post-transplant lymphoproliferative disease in solid organ transplantation in Europe. Results of the ESGICH Questionnaire-based Cross-sectional Survey

    Clinical Microbiology and Infection, Vol. 21, Núm. 6, pp. 604.e1-604.e9

  2. Effect of delaying prophylaxis against CMV in D+/R- solid organ transplant recipients in the development of CMV-specific cellular immunity and occurrence of late CMV disease

    Journal of Infection, Vol. 71, Núm. 5, pp. 561-570

  3. Effect of long-term prophylaxis in the development of cytomegalovirus-specific T-cell immunity in D+/R- solid organ transplant recipients

    Transplant Infectious Disease, Vol. 17, Núm. 5, pp. 637-646

  4. Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation

    Journal of Heart and Lung Transplantation, Vol. 34, Núm. 8, pp. 1112-1119

  5. Mycobacterium abscessus pulmonary infection complicated with vertebral osteomyelitis in a heart transplant recipient: Case report and literature review

    Transplant Infectious Disease, Vol. 17, Núm. 3, pp. 418-423

2014

  1. Efficacy and safety of a booster dose of influenza vaccination in solid organ transplant recipients, TRANSGRIPE 1-2: Study protocol for a multicenter, randomized, controlled clinical trial

    Trials, Vol. 15, Núm. 1

2013

  1. Epstein-barr virus DNAemia is an early surrogate marker of the net state of immunosuppresion in solid organ transplant recipients

    Transplantation, Vol. 95, Núm. 5, pp. 688-693

  2. Executive summary. Management of influenza infection in solid-organ transplantrecipients: Consensus statement of the Group for the Study of Infection In Transplant Recipients (GESITRA) of the Spanish Society of Infectious Diseases Andclinical Microbiology (SEIMC) and the Spanish Network for Research in Infectious Diseases (REIPI)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 31, Núm. 8, pp. 528-534

  3. Management of influenza infection in solid-organ transplant recipients:consensus statement of the group for the study of infection in transplantrecipients (GESITRA) of the spanish society of infectious diseases and clinicalmicrobiology (SEIMC) and the spanish network for research in infectiousdiseases (REIPI)

    Enfermedades Infecciosas y Microbiologia Clinica, Vol. 31, Núm. 8, pp. 526.e1-526.e20

2009

  1. A new strategy of delayed long-term prophylaxis could prevent cytomegalovirus disease in (D+/R-) solid organ transplant recipients

    Clinical Transplantation, Vol. 23, Núm. 5, pp. 666-671

2007

  1. Clinical implications of respiratory virus infections in solid organ transplant recipients: A prospective study

    Transplantation, Vol. 84, Núm. 7, pp. 851-856